Literature DB >> 20936381

Infantile acute lymphoblastic leukemia and nephromegaly.

Ketan P Kulkarni, Laxman Singh Arya.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20936381     DOI： 10.1007/s12098-010-0164-4

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  6 in total

1.  Precursor B-cell lymphoblastic leukemia as a cause of a bilateral nephromegaly.

Authors:  Anelia Boueva; Raymonde Bouvier
Journal:  Pediatr Nephrol       Date:  2005-02-16       Impact factor: 3.714

2.  T-cell lymphoblastic leukemia in early childhood presents NOTCH1 mutations and MLL rearrangements.

Authors:  Marcela Braga Mansur; Mariana Emerenciano; Alessandra Splendore; Lilian Brewer; Rocio Hassan; Maria S Pombo-de-Oliveira
Journal:  Leuk Res       Date:  2009-07-24       Impact factor: 3.156

3.  Acute lymphoblastic leukemia: an unusual cause of nephromegaly in infancy.

Authors:  Mukta Mantan; Kamal Kumar Singhal; Gulshan Rai Sethi
Journal:  Indian J Pediatr       Date:  2010-05       Impact factor: 1.967

Review 4.  High-risk childhood acute lymphoblastic leukemia.

Authors:  Deepa Bhojwani; Scott C Howard; Ching-Hon Pui
Journal:  Clin Lymphoma Myeloma       Date:  2009

5.  Central nervous system involvement at presentation in childhood acute lymphoblastic leukemia: management experience and lessons.

Authors:  Ram K Marwaha; Ketan P Kulkarni; Deepak Bansal; Amita Trehan
Journal:  Leuk Lymphoma       Date:  2010-02

6.  Prognostic value of nephromegaly at diagnosis of childhood acute lymphoblastic leukemia.

Authors:  P D'Angelo; R Mura; C Rizzari; V Conter; F Bellini; M G Valsecchi; C Manganini; D Silvestri; G Masera
Journal:  Acta Haematol       Date:  1995       Impact factor: 2.195
  6 in total
  1 in total

1.  Precursor B-cell acute lymphoblastic leukemia: An unusual cause of bilateral nephromegaly in an infant.

Authors:  D Ramadoss; S Karande; M Muranjan; P Wagle
Journal:  J Postgrad Med       Date:  2017 Oct-Dec       Impact factor: 1.476
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.